banner
2'-Azido-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-5-methyluridine
Inquiry

Cat. No.: X25-06-LY889

2'-Azido-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-5-methyluridine

Synonym: 2095417-08-4; 1-[(2R,3R,4S,5R)-3-Azido-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione

  • CAS Number: 2095417-08-4
  • Compound CID: 171361604
img
Product Size
50 mg; 100 mg; 250 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
2'-Azido-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-5-methyluridines is a modified uridine with an azide group. The presence of the 5 '-O-(4,4'-dimethoxy-triphenylmethyl) protecting group makes it more stable in nucleotide synthesis.
Molecular Weight
585.61
Molecular Formula
C31H31N5O7
Form
Solid
Purity
≥95.0%
Applications
2'-Azido-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-5-methyluridine can be used in the synthesis of active molecules, especially in labeling and probe design. Azide groups are typically employed in click chemical reactions and are utilized in RNA research to explore the structure and function of RNA.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0